Cognoptix developing an Alzheimer’s disease test using the eye

Cognoptix developing an Alzheimer’s disease test using the eye

Cognoptix Inc CEO Susanne Wilke sat down with Proactive’s Christine Corrado at the Biotech Showcase 2020 in San Francisco. The Concord, Massachusetts-based company develops non-invasive eye tests for the early diagnosis of Alzheimer’s disease. Read more >>

Share this post